Article
S100A8 may govern hyper-inflammation in severe COVID-19.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Sept 2021
Deguchi Atsuko, Yamamoto Tomoko, Shibata Noriyuki, Maru Yoshiro
Abstract excerpt
The coronavirus disease 2019 (COVID-19) pandemic threatens human species with mortality rate of roughly 2%. We can hardly predict the time of herd immunity against and end of COVID-19 with or without success of vaccine. One way to overcome the situation is to define what delineates disease severity and serves as a molecular target. The most successful analogy is found in BCR-ABL in chronic myeloid leukemia, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
